Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2028 250

  1. Primary completion Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471282

  2. Primary completion Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07526649

  3. Study completion Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07526987

  4. Primary completion Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07526987

  5. Study completion AI-Assisted Workflow for Occult Atrial Fibrillation Detection After Ischemic Stroke: A Prospective Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07540065

  6. Primary completion AI-Assisted Workflow for Occult Atrial Fibrillation Detection After Ischemic Stroke: A Prospective Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07540065

  7. Study completion A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07555054

  8. Study completion Clinical, Organizational, and Care Impact of the GetReady Digital Platform as a Clinical Decision Support Tool in the Follow-up of Patients With Cerebral Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07569562

  9. Primary completion Clinical, Organizational, and Care Impact of the GetReady Digital Platform as a Clinical Decision Support Tool in the Follow-up of Patients With Cerebral Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07569562

  10. Study completion GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613437

  11. Study completion SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07614230

  12. Study completion Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07616544

  13. Primary completion In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07622485

  14. Study completion fNIRS for Monitoring Cortical Activity in Stroke Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07623512

  15. Primary completion fNIRS for Monitoring Cortical Activity in Stroke Recovery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07623512

  16. Study completion Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07704190

  17. Primary completion Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07704190

  18. Study completion Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07713914

  19. Study completion Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07719894

  20. Primary completion Digital Long-term Follow-up of Patients With Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07720349

  21. Study completion INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07727395

  22. Primary completion INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07727395

  23. Study completion Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07760922

  24. Primary completion Tirofiban Combined With Aspirin in Moderate Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07760922

  25. Primary completion Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07762755

  26. Study completion Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07763405

  27. Primary completion Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07763405

  28. Primary completion IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796412

  29. Study completion The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07818083

  30. Primary completion Unimanual Versus Bimanual Motor Skill Learning in Acute and Chronic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07826832

  31. Study completion Utility of the Perclose ProGlide™ Suture-Mediated Closure Device After Cardiologic Procedures Via the Femoral Vein Approach (Eight-Clover) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07827287

  32. Study completion Combined Acupuncture-Based Therapy for Rehabilitation After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07846488

  33. Primary completion Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07874594

  34. Study completion Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07876544

  35. Primary completion Sitogilun Malate Plus Amlodipine in Patients With Hypertension and Risk of Early Kidney Damage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07876544

  36. Primary completion Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07917078

January 2029 46

  1. Primary completion Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05700877

  2. Primary completion Beta-blockade in Unruptured Intracranial Aneurysm Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06249802

  3. Primary completion Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06468202

  4. Primary completion Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06725810

  5. Study completion Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07324837

  6. Primary completion STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07644247

  7. Primary completion RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07819643

  8. Study completion Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07858331

  9. Primary completion Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07858331

  10. Primary completion Avoiding Anticoagulation After IntraCerebral Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03243175

  11. Primary completion Amplatzer Amulet LAAO vs. NOAC Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04226547

  12. Study completion POHCA Resuscitation: Evaluation of IM Epinephrine Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05166343

  13. Study completion Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05846893

  14. Primary completion Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06870448

  15. Primary completion HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07123779

  16. Primary completion Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07227246

  17. Study completion Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07314775

  18. Study completion Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07434661

  19. Study completion Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07658807

  20. Study completion ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07737964

  21. Primary completion ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07737964

  22. Primary completion Randomized Interventional Clinical Trial on the Prevention of Atrial Fibrillation Using Colchicine, Amiodarone And a Posterior Pericardiotomy. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07887022

  23. Study completion MUTTON-HF Pilot Expansion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07922863

  24. Study completion Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07189234

  25. Study completion Dapagliflozin for Cardio-renal Protection After ICU Discharge Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07025629

  26. Primary completion Dapagliflozin for Cardio-renal Protection After ICU Discharge Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07025629

  27. Study completion Permanent Conduction System Pacing Versus Atrioventricular Management for Patients With Wide QRS and Patent AV Conduction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07585799

  28. Study completion A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07843485

  29. Study completion A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07481981

  30. Primary completion A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07816185

  31. Primary completion DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07322237

  32. Study completion IVUS-Guided Sirolimus-Coated Balloon Versus Sirolimus-Eluting Stent for De Novo Large Vessel Lesions in ACS Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07796412

  33. Study completion 2019-06 TRISCEND Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04221490

  34. Primary completion Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05963568

  35. Primary completion StrokeNet Thrombectomy Endovascular Platform Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06289985

  36. Primary completion Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06571149

  37. Primary completion Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06872684

  38. Study completion Left Bundle Branch Versus Minimized Ventricular Pacing in Patients With Sick Sinus Syndrome and Prolonged AV Interval Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07314008

  39. Primary completion Left Bundle Branch Versus Minimized Ventricular Pacing in Patients With Sick Sinus Syndrome and Prolonged AV Interval Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07314008

  40. Study completion Efficacy and Safety of Micra AV2 Transcatheter Pacing System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07356505

  41. Study completion Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07444372

  42. Primary completion Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07444372

  43. Study completion Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07511543

  44. Primary completion Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07668323

  45. Primary completion APEX-STROKE CALM-ICH Domain Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752719

  46. Primary completion Infarct Growth After Intravenous Tocilizumab in Adults With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy - ILLUMINATE Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870681

February 2029 40

  1. Study completion Assessment of CCM in HF With Higher Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05064709

  2. Primary completion Assessment of CCM in HF With Higher Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05064709

  3. Study completion Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05963568

  4. Study completion Physiology of Unloading VA ECMO Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06336655

  5. Study completion Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06725810

  6. Study completion Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07046273

  7. Primary completion HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07379190

  8. Study completion Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07846579

  9. Study completion Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05465031

  10. Study completion The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06383390

  11. Primary completion The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06383390

  12. Primary completion CGM for Management of Type 2 Diabetes in Pregnancy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06628453

  13. Study completion ELEVATE-HFpEF Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06678841

  14. Primary completion Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06777901

  15. Study completion Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07083765

  16. Study completion Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07245069

  17. Study completion HEARTS in Sync + CardioWatch 287-2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07322510

  18. Study completion CLEANer Aspiration for Pulmonary Embolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06189313

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion DIAbetes Maximal ACCeleration Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05646147

  2. Study completion Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response Registry record

    Expected 2025-01-31; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691959

  3. Primary completion Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response Registry record

    Expected 2025-01-31; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05691959

  4. Study completion The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05844644

  5. Primary completion METFORMIN FOR ATRIAL FIBRILLATION Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05878535

  6. Primary completion A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE) Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05961787

  7. Primary completion CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke Registry record

    Expected 2025-01-31; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06078215

  8. Study completion EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06138834

  9. Primary completion Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06196177

  10. Study completion Impact of Sleep Quality on Outcomes After Cardiac Surgery Registry record

    Expected 2025-01-31; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06527105

  11. Study start Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure Registry record

    Expected 2025-01-31; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06669169

  12. Study start Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06712030

  13. Study start Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06756945

  14. Study start Evaluating the Safety and Efficacy of Drug-Coated Autoperfusion Balloons Versus Conventional Drug-Coated Balloons Guided by IVUS-OCT Multimodal Imaging for Treating Acute Myocardial Infarction: OPERA-AMI Study Registry record

    Expected 2025-01; that period ended on 2025-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06794801

  15. Study completion Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05209412

  16. Primary completion Future Patient - Telerehabilitation of Patients With Atrial Fibrillation Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06101485

  17. Study completion Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06102720

  18. Study start Oral Bedtime Melatonin in Critically Ill Patients Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06156059

  19. Primary completion Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B ) Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06492265

  20. Primary completion Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06652750

  21. Study start StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06785727

  22. Study start Adjuvant Cerebroprotection Using Normobaric Hyperoxia in Pre-hospital Patients with Suspected Stroke Registry record

    Expected 2025-02-01; that period ended on 2025-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06801457

  23. Study completion Brain Connectivity Measured With High-density Electroencephalography Registry record

    Expected 2025-02-02; that period ended on 2025-02-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06298097

  24. Primary completion Brain Connectivity Measured With High-density Electroencephalography Registry record

    Expected 2025-02-02; that period ended on 2025-02-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06298097

  25. Study completion Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients Registry record

    Expected 2025-02-03; that period ended on 2025-02-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06717685

  26. Primary completion Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins Registry record

    Expected 2025-02-10; that period ended on 2025-02-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06262685

  27. Study completion OCT Guided Magmaris RMS in STEMI Registry record

    Expected 2025-02-15; that period ended on 2025-02-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03955731

  28. Primary completion OCT Guided Magmaris RMS in STEMI Registry record

    Expected 2025-02-15; that period ended on 2025-02-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03955731

  29. Study start Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation Registry record

    Expected 2025-02-15; that period ended on 2025-02-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06791629

  30. Study completion The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis Registry record

    Expected 2025-02-18; that period ended on 2025-02-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04733443

  31. Study completion Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD Registry record

    Expected 2025-02-18; that period ended on 2025-02-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05359263

  32. Primary completion Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD Registry record

    Expected 2025-02-18; that period ended on 2025-02-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05359263

  33. Primary completion GD-11 for Injection in the Treatment of Acute Ischemic Stroke Registry record

    Expected 2025-02-22; that period ended on 2025-02-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06299579

  34. Study completion Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02661451

  35. Study completion Hemodialysis in the Elderly (70yrs & Older) Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03065972

  36. Primary completion Hemodialysis in the Elderly (70yrs & Older) Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03065972

  37. Study completion PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03970538

  38. Study completion Ankle Robotics After Stroke Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04594837

  39. Primary completion Ankle Robotics After Stroke Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04594837

  40. Study completion Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05006105

  41. Primary completion Early Detection of Atrial Fibrillation Using Mobile Technology in Cryptogenic Stroke Patients Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05006105

  42. Study completion Clinical Impact of the IBox As an Early Intervention TooL Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05112315

  43. Primary completion Clinical Impact of the IBox As an Early Intervention TooL Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05112315

  44. Study completion Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05240781

  45. Study completion Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05431296

  46. Primary completion Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487261

  47. Study completion Safety and Effectiveness of Left Bundle Branch Pacing in Patients With Cardiac Dysfunction and AV Block Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05553626

  48. Study completion Clinical Study of Focal Implant Used for Lower Extremity Post-angioplasty Dissection Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05562076

  49. Study completion Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05634382

  50. Study completion DCB Under the Guidance of OCT in STEMI Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05680051

  51. Primary completion Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05887817

  52. Study completion Effects of Levosimendan on Cardiac Function After TAVR in Patients With Heart Failure Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06196177

  53. Study completion MCG for Localization of Tachyarrhythmia's Origin Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06327425

  54. Study completion Phase III Study to Evaluate the Efficacy and Safety of AD-209 Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06348576

  55. Primary completion Phase III Study to Evaluate the Efficacy and Safety of AD-209 Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06348576

  56. Study completion The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06408532

  57. Primary completion Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06441539

  58. Primary completion The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus. Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06579066

  59. Primary completion Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06616961

  60. Primary completion Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence Registry record

    Expected 2025-02-28; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06644339

  61. Study start Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06750341

  62. Study start Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06759272

  63. Study start Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06785974

  64. Study start Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment Registry record

    Expected 2025-02; that period ended on 2025-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06788626

  65. Study start Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06115070

  66. Study completion The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06224296

  67. Primary completion Topical Nitro or Placebo Pre-Cath Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06289946

  68. Study start CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06814210

  69. Study start Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06820567

  70. Study start Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06841965

  71. Study start Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06841978

  72. Study start Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol Registry record

    Expected 2025-03-01; that period ended on 2025-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06845254

  73. Study completion Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins Registry record

    Expected 2025-03-04; that period ended on 2025-03-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06262685

  74. Primary completion Cerebroprotective Effect of Melatonin in Stroke Registry record

    Expected 2025-03-15; that period ended on 2025-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05857046

  75. Primary completion Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients Registry record

    Expected 2025-03-15; that period ended on 2025-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05957887

  76. Study start A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy Registry record

    Expected 2025-03-15; that period ended on 2025-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06702657

  77. Study start Transcutaneous Laser Therapy in Chronic Kidney Disease Registry record

    Expected 2025-03-17; that period ended on 2025-03-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06855992

  78. Primary completion Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) Registry record

    Expected 2025-03-20; that period ended on 2025-03-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06030544

  79. Primary completion Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features Registry record

    Expected 2025-03-30; that period ended on 2025-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05131139

  80. Study completion Analysis of the Efficacy and Stability of a Wearable ECG Monitor Registry record

    Expected 2025-03-30; that period ended on 2025-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06546046

  81. Study completion Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01627821

  82. Primary completion Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01627821

  83. Study completion Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02342444

  84. Study completion Safety and Efficacy Study of Abdominal Aortic Aneurysm Stent Graft System Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03687489

  85. Study completion Optimising Pacing for Contractility 2 Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04201015

  86. Study completion Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04511468

  87. Study completion Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER) Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05164653

  88. Study completion Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05236348

  89. Primary completion Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05236348

  90. Study completion Reducing Edema After intraCerebral Hemorrhage Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05263167

  91. Primary completion Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05327062

  92. Study completion The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05803759

  93. Study completion CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06078215

  94. Primary completion Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06203236

  95. Study completion Topical Nitro or Placebo Pre-Cath Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06289946

  96. Primary completion BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06322394

  97. Primary completion Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06378021

  98. Study completion BraiN20® Medical Device in Suspected Acute Stroke Patients Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06421337

  99. Study start Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06473116

  100. Study completion The Effect of Probiotics vs Activated Charcoal in the Management of CKD Patients Suffering From Uremic Pruritus. Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06579066